Muraglitazar, a novel non-TZD dual PPAR α/γ agonist, improves metabolic abnormalities in obese, severely diabetic db/db mice

被引：0
|
作者：
Harrity, T
Chu, CX
Kunselman, L
Ponticiello, R
Cap, M
Cheng, P
Hariharan, N
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A31 / A32
页数：2
相关论文
共 50 条
  • [1] Increase in weight induced by muraglitazar, a dual PPARα/γ agonist, in db/db mice:: adipogenesis/or oedema?
    Mittra, S.
    Sangle, G.
    Tandon, R.
    Sharma, S.
    Roy, S.
    Khanna, V.
    Gupta, A.
    Sattigeri, J.
    Sharma, L.
    Priyadarsiny, P.
    Khattar, S. K.
    Bora, R. S.
    Saini, K. S.
    Bansal, V. S.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 150 (04) : 480 - 487
  • [2] PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
    Park, CW
    Zhang, Y
    Zhang, X
    Wu, J
    Chen, L
    Cha, DR
    Su, D
    Hwang, MT
    Fan, X
    Davis, L
    Striker, G
    Zheng, F
    Breyer, M
    Guan, Y
    KIDNEY INTERNATIONAL, 2006, 69 (09) : 1511 - 1517
  • [3] Pharmacological profile of a novel, non-TZD PPARγ agonist
    Chen, X
    Osborne, MC
    Rybczynski, PJ
    Zeck, R
    Yang, M
    Xu, J
    Zhou, L
    Cryan, E
    Tang, Y
    Demarest, KT
    DIABETES OBESITY & METABOLISM, 2005, 7 (05): : 536 - 546
  • [4] Muraglitazar, a dual (α/γ PPAR activator, prevents onset of diabetes in pre-diabetic db/db mice, ameliorates diabetes in severely diabetic db/db mice, and preserves β-cell function in both mouse models
    Hariharan, N
    Tozzo, E
    Harrity, T
    Welzel, G
    Chu, C
    Ponticiello, R
    Egan, D
    Russ, R
    Peters, A
    Farrelly, D
    Cheng, PT
    DIABETOLOGIA, 2005, 48 : A275 - A275
  • [5] Muraglitazar, a novel dual (α/γ) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves β-cell function in db/db mice
    Harrity, T
    Farrelly, D
    Tieman, A
    Chu, CX
    Kunselman, L
    Gu, LQ
    Ponticiello, R
    Cap, M
    Qu, FC
    Shao, CN
    Wang, W
    Zhang, H
    Fenderson, W
    Chen, S
    Devasthale, P
    Jeon, Y
    Seethala, R
    Yang, WP
    Ren, J
    Zhou, M
    Ryono, D
    Biller, S
    Mookhtiar, KA
    Wetterau, J
    Gregg, R
    Cheng, PT
    Hariharan, N
    DIABETES, 2006, 55 (01) : 240 - 248
  • [6] Tesaglitazar, a dual PPARα/γ agonist, restores cardiac metabolic flexibility in the diabetic (db/db) mouse
    Edgley, Amanda
    Thalen, Pia
    Ljung, Bengt
    Oakes, Nick
    DIABETES, 2006, 55 : A110 - A111
  • [7] Efficacy of LY519818, a novel non-TZD, PPARγ-dominant αγ dual agonist
    Prince, M
    Spicer, K
    Caro, J
    Abu-Raddad, E
    Konrad, R
    Wang, MD
    Negrovilar, A
    Dananberg, J
    DIABETES, 2004, 53 : A33 - A33
  • [8] Treatment of type 2 diabetic db/db mice with a novel PPARγ agonist improves cardiac metabolism but not contractile function
    Carley, AN
    Semeniuk, LM
    Shimoni, Y
    Aasum, E
    Larsen, TS
    Berger, JP
    Severson, DL
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2004, 286 (03): : E449 - E455
  • [9] Long-term treatment of young prediabetic db/db mice with muraglitazar, a novel dual PPAR α/γ agonist, prevents hyperglycemia and preserves pancreatic β-cell function
    Tozzo, E
    Welzel, G
    Egan, D
    Russ, R
    Peters, A
    Farrelly, D
    Harrity, T
    Cheng, PTW
    Hariharan, N
    DIABETES, 2005, 54 : A66 - A66
  • [10] Adiponectin Improves Cardiomyocyte Contractile Function in db/db Diabetic Obese Mice
    Dong, Feng
    Ren, Jun
    OBESITY, 2009, 17 (02) : 262 - 268
12345